Location: Home
  • search
  • go
  • Relate News
  • 2/21/2017Three Central Agencies Issue Policy to Reinforce BMI Budgeting to Rein...
  • 2/21/2017Upcoming Event: Pharma China Annual Forum 2017 in Shanghai on April 14
  • 2/21/2017CFDA Approves Clinical Trial Applications of Four H7N9 Bird Flu Vaccin...
  • 2/21/2017Figuring Out Reimbursement Policies in China
  • 2/21/2017Qilu Pharma Launches First Generic of AZ's Anticancer Iressa
  • 2/21/2017China to Slash Drug Distribution Groups in Price Drive
  • 2/21/2017China's State Council Announces Major Policies to Reform the Pharmaceu...
  • 2/16/2017Recent Executive Moves
  • 2/16/2017CFDA Releases Three Technical Guidelines for Generic Drug Equivalence ...
  • 2/16/2017India Pressures CFDA to Act and Restore Supply of Rare Disease API
  • 2/15/2017Lee's Pharma Licenses Greater China Rights of Episil from Solasia
  • 2/15/2017GBI: Asia-Pacific Influenza Vaccines Market to Surpass $1.7B by 2022
  • 2/15/2017Chinese Animal Vaccine Market to Reach CNY 41 Bln by 2020
  • 2/15/2017CSL Reports Strong China Business, Helped by Rising Demand for Its Alb...
  • 2/15/2017China Works to Reduce Massive Backlog of Clinical Trial and Marketing ...
  • 2/14/2017Can Technology Really Solve China's Healthcare Crisis?
  • 2/14/2017PhRMA Urges USTR to Protect US Innovation Abroad
  • 2/14/2017CFDA Issues Incentive Measures for Food and Drug Companies with A Cred...
  • 2/14/2017Upcoming Event: Pharma China Annual Forum 2017 in Shanghai on April 14
  • 2/14/2017State Council Issues Medium and Long Term Plan for Prevention and Trea...
  • 2/14/2017China Cracks Down on First Pharma Antimonopoly Case in 2017
  • 2/13/2017China's Tech Tycoons' Healthcare Dreams Aren't Coming True
  • 2/13/2017Chinese Biotech Cstone Raises $150 Million in New Financing
  • 2/13/2017Inovio, ApolloBio Enter Licensing Deal for Greater China Rights of HPV...
  • 2/13/2017Five Elements to Consider When Choosing the Next Emerging Market to En...
  • 2/13/2017MOHRSS Expected to Issue Policy for Uniform BMI Payment Standards in Q...
  • 2/12/2017EU: Chinese Biopharma R&D Investment Growth Highest Globally at 27...
  • 2/12/2017Data Snapshot - Hospital Consumption COPD Drugs in Shanghai
  • 2/10/2017Baidu Withdraws from Mobile Healthcare to Focus on AI-enabled Services
  • 2/9/2017TaiGen Reports Positive Phase II Results for Its HCV Drug
  • Page:387/789 Total number of articles:23668: [First][<<] [385] [386] [387] [388] [389] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group